Dermatology/Allergy Visit Note

A concise veterinary template for companion animal pruritus and allergy workups. Emphasizes ectoparasite control documentation, cytology-based infection assessment, diet history capture, and trial-based treatment plannin…

Document Type

clinical note / Progress Note

Specialties

Veterinary
Created by Augustun

Template Preview

Date/Time: [Date and time of visit]

Patient: [Name], [Species], [Breed], [Age], [Sex], [Weight]

Client: [Owner name]

Visit Type: [new / recheck / urgent]

Referring DVM: [Name and clinic] (Only include if applicable)

History

Chief Complaint: [Client-stated concern and clinical terminology for presenting signs including onset, duration, progression, distribution, seasonality, and response to prior therapies] (If key elements are unavailable, document as "unknown.")

Owner Pruritus Score (0-10): [Current score] (For rechecks, include baseline/previous: [value] and trend: [improved / stable / worsened].)

Prior Therapies: [Topicals, systemic therapies, ear treatments, and response/adverse effects]

Ectoparasite Control

  • Current product and last dose: [product name, date]
  • All in-contact pets treated: [yes / no / unknown]
  • Exposure risk: [indoor only / indoor-outdoor / boarding / dog park / grooming]

Diet History

  • Current diet: [brand, protein sources, formulation]
  • Treats/table foods: [items] (If none, state none.)
  • Flavored meds/preventives: [list or none]
  • Prior diet trial: [diet, duration, compliance, response] (If none, state none.)
  • Feasibility concerns: [household factors if diet trial planned]

Objective

Vitals/BCS: [Weight, temperature if measured, body condition]

General Exam: [Brief assessment; note non-dermatologic abnormalities or state unremarkable]

Dermatologic Exam

  • Lesion morphology: [observed lesion types]
  • Distribution: [affected regions, note symmetry and predominant areas]
  • Synthesis: [Brief statement linking morphology to distribution and suspected primary vs secondary lesions]

Otic Exam (Only include if ears involved)

  • Left ear: [pinna, canal, discharge character, pain/pruritus, otoscopic findings if performed]
  • Right ear: [pinna, canal, discharge character, pain/pruritus, otoscopic findings if performed]

Cytology (If not performed, document reason deferred and plan to obtain.)

  • Site: [location] — Method: [tape / swab / impression / FNA]
    • Findings: [bacteria type and quantity, yeast quantity, inflammatory cells]
    • Interpretation: [infection / colonization / contamination] — Culture indicated: [yes / no with rationale]

Assessment

(List problems in order of clinical importance. Do not document a definitive diagnosis without supporting criteria and completed rule-outs or trials.)

[Problem 1]: [Primary problem]

  • Evidence: [Key history, distribution, morphology, cytology findings]
  • Differentials: [Prioritized list]
  • Working diagnosis: [Diagnosis] — Confidence: [low / moderate / high]

[Problem 2]: [Secondary problem]

  • Evidence: [Findings]
  • Differentials: [Prioritized list]
  • Working diagnosis: [Diagnosis] — Confidence: [low / moderate / high]

(Add additional problems as needed.)

Plan

(Organize by problem with start/stop/continue actions. For treatment trials, document rationale, intervention, success/failure criteria, and recheck timing.)

[Problem 1 Plan]

  • Start: [New therapies]
  • Continue: [Ongoing therapies]
  • Stop/Taper: [Therapies to discontinue]
  • Success/failure criteria: [Target outcomes and escalation triggers]
  • Recheck: [Interval and what will be reassessed]

[Problem 2 Plan]

  • Start: [Details]
  • Continue: [Details]
  • Stop/Taper: [Details]
  • Success/failure criteria: [Details]
  • Recheck: [Details]

Ectoparasite Control Trial (Include if indicated)

  • Product: [name, dose, frequency]; all in-contact pets treated: [yes / no]
  • Duration: [weeks]; Success criteria: [reduced pruritus, resolution of bite lesions]

Antimicrobial Therapy (Include if treating infection)

  • Indication: [pyoderma / Malassezia / otitis]
  • Agent and dosing: [topical/systemic, dose, frequency, duration]
  • Recheck/culture plan: [interval and criteria for culture]

Diet Trial (Include if planned)

  • Selected diet: [hydrolyzed / novel protein, brand]
  • Strict rules: Permitted items only; no treats/table scraps/flavored meds unless diet-approved
  • Duration: [8-12 weeks]; Challenge phase: [plan if improved]

Recheck Criteria

  • Scheduled: [interval]
  • Reassess: [pruritus score, cytology, lesion status, treatment tolerance]
  • Earlier return if: [worsening signs, new lesions, adverse effects]

Medications

  • [Medication] — [dose, route, frequency, duration]; Indication: [reason]; Instructions: [key notes]

(If none prescribed, state "None.")

Want to use this template?

Copy it into your workflow, or book a demo to see Augustun draft notes like this automatically.